Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front. Med.    2017, Vol. 11 Issue (3) : 440-444    https://doi.org/10.1007/s11684-017-0523-x
CASE REPORT
Philadelphia chromosome-positive acute myeloid leukemia with masses and osteolytic lesions: finding of 18F-FDG PET/CT
Zhan Su1,2, Fengyu Wu3, Weiyu Hu4, Xiaodan Liu2, Shaoling Wu2, Xianqi Feng2, Zhongguang Cui2, Jie Yang2, Zhenguang Wang3, Hongzai Guan5, Hongguo Zhao2, Wei Wang2, Chunting Zhao2(), Jun Peng1()
1. Department of Haematology, Qilu Hospital, Shandong University, Jinan 250012, China
2. Department of Haematology, The Affiliated Hospital of Qingdao University, Qingdao 266000, China
3. PET/CT Center, The Affiliated Hospital of Qingdao University, Qingdao 266000, China
4. Department of Hepatobiliary Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266000, China
5. Department of Haematology, Qingdao University Medical College, Qingdao 266071, China
 Download: PDF(202 KB)   HTML
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract

Philadelphia chromosome-positive acute myeloid leukemia is controversial and difficult to distinguish from the blast phase of chronic myeloid leukemia. As a myeloid neoplasm, rare cases of this leukemia manifest multiple soft-tissue tumors or bone lytic lesions. In this paper, we describe a 49-year-old male patient who had an abrupt onset with sharp chest pain, fever, fatigue, emaciation, and splenomegaly. 18F-fluoro-deoxy-glucose positron emission tomography/computed tomography (18F-FDG PET/CT) result showed diffuse and uneven hypermetabolic lesions in the bone marrow with peripheral bone marrow expansion, multiple soft tissue neoplasms with high 18F-FDG uptake, and lytic bone lesions. Bone marrow smear and biopsy detected aberrant blast cells expressing myeloid rather than lymphoid immunophenotype marker. For the existence of Philadelphia chromosome and BCR-ABL1 fusion gene together with complex chromosome abnormalities, a diagnosis of Philadelphia-positive acute myeloid leukemia was made, although the type (de novo or blast crisis) remained unclear.

Keywords Philadelphia chromosome      acute myeloid leukemia      mass      osteolysis      positron emission tomography     
Corresponding Author(s): Chunting Zhao,Jun Peng   
Just Accepted Date: 25 April 2017   Online First Date: 26 May 2017    Issue Date: 29 August 2017
 Cite this article:   
Zhan Su,Fengyu Wu,Weiyu Hu, et al. Philadelphia chromosome-positive acute myeloid leukemia with masses and osteolytic lesions: finding of 18F-FDG PET/CT[J]. Front. Med., 2017, 11(3): 440-444.
 URL:  
https://academic.hep.com.cn/fmd/EN/10.1007/s11684-017-0523-x
https://academic.hep.com.cn/fmd/EN/Y2017/V11/I3/440
Fig.1  Morphological features and results of cytogenetic and molecular analyses. (A and B) May?Grümwald?Giemsa-stained blood and bone marrow smears (1000×). (C) Representative karyotype of leukemic cells with t(9;22)(q34;p11); arrows indicate the Ph translocation. (D) Sequencing results of BCR-ABL1 transcript. Sequences flanking the breakpoint are shown, and BCR exon b3 is fused to ABL1 exon a2.
Fig.2  (A) PET showed diffused and uneven high FDG uptake in the bone marrow and CT displayed density heterogeneously increased in those abnormal metabolic sites. Multiple soft tissue density foci were observed in the medullary cavity of bilateral femurs. (B) PET/CT showed multiple FDG-avid soft-tissue density masses in the right chest wall, around the sternum, the thoracic vertebra, and in the thoracic subcutaneous space. The biggest mass was located in the right chest wall, with osteolytic destruction in the 8th right rib. The spleen was considerably enlarged with diffused high FDG uptake.
1 Frankfurt O, Platanias LC. Philadelphia chromosome positive acute myeloid leukemia or de novo chronic myeloid leukemia-blast phase? Leuk Lymphoma 2013; 54(1): 1–2
https://doi.org/10.3109/10428194.2012.713105 pmid: 22891690
2 Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC, 2008
3 Dutta S, Kumari P, Natraj KS, Mandal PK, Saha S, Bagchi B, Choudhuri S, Dolai TK. Philadelphia chromosome-positive myelodysplastic syndrome: is it a distinct entity? Acta Haematol 2013; 129(4): 215–217
https://doi.org/10.1159/000345263 pmid: 23295538
4 Berger R. Differences between blastic chronic myeloid leukemia and Ph-positive acute leukemia. Leuk Lymphoma 1993; 11(Suppl 1): 235–237
https://doi.org/10.3109/10428199309047892 pmid: 8251902
5 Soupir CP, Vergilio JA, Dal Cin P, Muzikansky A, Kantarjian H, Jones D, Hasserjian RP. Philadelphia chromosome-positive acute myeloid leukemia: a rare aggressive leukemia with clinicopathologic features distinct from chronic myeloid leukemia in myeloid blast crisis. Am J Clin Pathol 2007; 127(4): 642–650
https://doi.org/10.1309/B4NVER1AJJ84CTUU pmid: 17369142
6 Cuneo A, Ferrant A, Michaux JL, Demuynck H, Boogaerts M, Louwagie A, Doyen C, Stul M, Cassiman JJ, Dal Cin P, Castoldi G, Van den Berghe H. Philadelphia chromosome-positive acute myeloid leukemia: cytoimmunologic and cytogenetic features. Haematologica 1996; 81(5): 423–427
pmid: 8952155
7 Keung YK, Beaty M, Powell BL, Molnar I, Buss D, Pettenati M. Philadelphia chromosome positive myelodysplastic syndrome and acute myeloid leukemia-retrospective study and review of literature. Leuk Res 2004; 28(6): 579–586
https://doi.org/10.1016/j.leukres.2003.10.027 pmid: 15120934
8 Konoplev S, Yin CC, Kornblau SM, Kantarjian HM, Konopleva M, Andreeff M, Lu G, Zuo Z, Luthra R, Medeiros LJ, Bueso-Ramos CE. Molecular characterization of de novo Philadelphia chromosome-positive acute myeloid leukemia. Leuk Lymphoma 2013; 54(1): 138–144
https://doi.org/10.3109/10428194.2012.701739 pmid: 22691121
9 Nacheva EP, Grace CD, Brazma D, Gancheva K, Howard-Reeves J, Rai L, Gale RE, Linch DC, Hills RK, Russell N, Burnett AK, Kottaridis PD. Does BCR/ABL1 positive acute myeloid leukaemia exist? Br J Haematol 2013; 161(4): 541–550
https://doi.org/10.1111/bjh.12301 pmid: 23521501
10 Reboursiere E, Chantepie S, Gac AC, Reman O. Rare but authentic Philadelphia-positive acute myeloblastic leukemia: two case reports and a literature review of characteristics, treatment and outcome. Hematol Oncol Stem Cell Ther 2015; 8(1): 28–33
https://doi.org/10.1016/j.hemonc.2014.09.002 pmid: 25300567
11 Tucker D, Hamilton MS, Kerr JP, Wickham C, Hunter H. Lytic bone disease as the presenting feature of Philadelphia-positive monosomy 7 myelodysplasia progressing to acute myeloid leukaemia. Gene 2012; 501(2): 219–221
https://doi.org/10.1016/j.gene.2012.04.024 pmid: 22537673
12 Cribe AS, Steenhof M, Marcher CW, Petersen H, Frederiksen H, Friis LS. Extramedullary disease in patients with acute myeloid leukemia assessed by 18F-FDG PET. Eur J Haematol 2013; 90(4): 273–278
https://doi.org/10.1111/ejh.12085 pmid: 23470093
13 Vanderhoek M, Juckett MB, Perlman SB, Nickles RJ, Jeraj R. Early assessment of treatment response in patients with AML using [(18)F]FLT PET imaging. Leuk Res 2011; 35(3): 310–316
https://doi.org/10.1016/j.leukres.2010.06.010 pmid: 20832860
[1] Xiaowei Zhu, Houfeng Zheng. Factors influencing peak bone mass gain[J]. Front. Med., 2021, 15(1): 53-69.
[2] Heng Fang, Aihua Zhang, Xiaohang Zhou, Jingbo Yu, Qi Song, Xijun Wang. High-throughput metabolomics reveals the perturbed metabolic pathways and biomarkers of Yang Huang syndrome as potential targets for evaluating the therapeutic effects and mechanism of geniposide[J]. Front. Med., 2020, 14(5): 651-663.
[3] Meng Lv, Xiaohui Zhang, Lanping Xu, Yu Wang, Chenhua Yan, Huan Chen, Yuhong Chen, Wei Han, Fengrong Wang, Jingzhi Wang, Kaiyan Liu, Xiaojun Huang, Xiaodong Mo. Risk factors for chronic graft-versus-host disease after anti-thymocyte globulin-based haploidentical hematopoietic stem cell transplantation in acute myeloid leukemia[J]. Front. Med., 2019, 13(6): 667-679.
[4] Xiao He, Chentao Jin, Mindi Ma, Rui Zhou, Shuang Wu, Haoying Huang, Yuting Li, Qiaozhen Chen, Mingrong Zhang, Hong Zhang, Mei Tian. PET imaging on neurofunctional changes after optogenetic stimulation in a rat model of panic disorder[J]. Front. Med., 2019, 13(5): 602-609.
[5] Xiaoxiao Chen, Yanjing Tang, Jing Chen, Ru Chen, Longjun Gu, Huiliang Xue, Ci Pan, Jingyan Tang, Shuhong Shen. Homoharringtonine is a safe and effective substitute for anthracyclines in children younger than 2 years old with acute myeloid leukemia[J]. Front. Med., 2019, 13(3): 378-387.
[6] So Jung Yang, Hun-Sung Kim, Kun-Ho Yoon. Analyzing the distinguishing factors that affect childhood obesity in South Korea[J]. Front. Med., 2018, 12(6): 707-716.
[7] N.V. Vasilyeva, E.R. Raush, M.V. Rudneva, T.S. Bogomolova, A.E. Taraskina, Yong Fang, Fengmin Zhang, N.N. Klimko. Etiology of invasive candidosis agents in Russia: a multicenter epidemiological survey[J]. Front. Med., 2018, 12(1): 84-91.
[8] Yinjun Lou, Yafang Ma, Chenyin Li, Sansan Suo, Hongyan Tong, Wenbin Qian, Wenyuan Mai, Haitao Meng, Wenjuan Yu, Liping Mao, Juyin Wei, Weilei Xu, Jie Jin. Efficacy and prognostic factors of imatinib plus CALLG2008 protocol in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia[J]. Front. Med., 2017, 11(2): 229-238.
[9] Qanta A. Ahmed,Ziad A. Memish. Yellow fever and Hajj: with all eyes on Zika, a familiar flavivirus remains a threat[J]. Front. Med., 2016, 10(4): 527-530.
[10] Yuting Tan,Han Liu,Saijuan Chen. Mutant DNA methylation regulators endow hematopoietic stem cells with the preleukemic stem cell property, a requisite of leukemia initiation and relapse[J]. Front. Med., 2015, 9(4): 412-420.
[11] Tao Wang,Weiping Jia,Cheng Hu. Advancement in genetic variants conferring obesity susceptibility from genome-wide association studies[J]. Front. Med., 2015, 9(2): 146-161.
[12] Lei Li,Yimei Liu,Tiancheng Luo,Jian Zhou,Yingyong Hou,Xizhong Shen,Jiyao Wang. Comprehensive treatment of acute-on-chronic liver failure in a patient with hepatitis B: a case report[J]. Front. Med., 2014, 8(2): 250-253.
[13] Jingyi Lu, Guoxiang Xie, Weiping Jia, Wei Jia. Metabolomics in human type 2 diabetes research[J]. Front Med, 2013, 7(1): 4-13.
[14] Jia Wei, Jiexiong Feng. Laparoscopic treatment of liver diseases in children[J]. Front Med, 2011, 5(4): 388-394.
[15] Felicitas THOL, Arnold GANSER. Molecular pathogenesis of acute myeloid leukemia: A diverse disease with new perspectives[J]. Front. Med., 2010, 4(4): 356-362.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed